Infusion devices and related methods and systems for regulating insulin on board
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-005/172
A61M-005/145
A61M-005/168
A61M-005/142
출원번호
US-0261272
(2014-04-24)
등록번호
US-10232113
(2019-03-19)
발명자
/ 주소
Palerm, Cesar C.
출원인 / 주소
MEDTRONIC MINIMED, INC.
대리인 / 주소
Lorenz & Kopf, LLP
인용정보
피인용 횟수 :
0인용 특허 :
197
초록▼
Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a user involves determining a current amount of active fluid in the body of the user, determining a threshold amount of active fluid in t
Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a user involves determining a current amount of active fluid in the body of the user, determining a threshold amount of active fluid in the body of the user, and automatically altering operation of the infusion device to modify delivery of the fluid to the user based on a relationship between the current amount and the threshold amount.
대표청구항▼
1. A method of operating an infusion device operable to deliver fluid to a body of a user, the fluid influencing a physiological condition in the body, the method comprising: automatically suspending operation of the infusion device to deliver the fluid to the user based at least in part on a curren
1. A method of operating an infusion device operable to deliver fluid to a body of a user, the fluid influencing a physiological condition in the body, the method comprising: automatically suspending operation of the infusion device to deliver the fluid to the user based at least in part on a current measurement value for the physiological condition of the user;determining a current amount of active fluid in the body of the user;determining a steady state threshold value for the fluid that is active in the body of the user based on a basal infusion rate;after automatically suspending operation of the infusion device, when the current amount of active fluid is less than the steady state threshold value, automatically resuming operation of the infusion device to deliver the fluid to the user to regulate the current amount of active fluid to the steady state threshold value based on a difference between the current amount of active fluid and the steady state threshold value when the current measurement value for the physiological condition of the user is less than a threshold value for the physiological condition of the user; andautomatically suspending the delivery of the fluid when the current amount is greater than the steady state threshold value. 2. The method of claim 1, wherein determining the steady state threshold value comprises: determining a reduced delivery rate based on a nominal delivery rate for the fluid; anddetermining the steady state threshold value as a steady state result of the reduced delivery rate. 3. The method of claim 2, further comprising: generating a delivery command configured to regulate the current amount of active fluid to the steady state threshold value;generating a closed-loop delivery command based on a difference between the current measurement value for the physiological condition of the user and a target value for the physiological condition of the user, the closed-loop delivery command being configured to regulate the physiological condition of the user to the target value; andoperating the infusion device in accordance with the closed-loop delivery command when the closed-loop delivery command is greater than zero, wherein automatically resuming operation of the infusion device comprises: operating the infusion device in accordance with the delivery command when the closed-loop delivery command is less than or equal to zero. 4. The method of claim 1, wherein automatically resuming operation of the infusion device comprises automatically transitioning the infusion device from a suspend delivery mode to an alternative delivery mode configured to regulate the current amount of active fluid to the steady state threshold value when the current amount is less than the steady state threshold value. 5. The method of claim 1, further comprising: determining the current measurement value for the physiological condition of the user is less than a suspend enable threshold value; anddetermining a predicted value for the physiological condition of the user is less than a predictive suspend threshold value, wherein: automatically suspending operation of the infusion device comprises automatically disabling operation of the infusion device to deliver the fluid to the user when the current measurement value is less than the suspend enable threshold value and the predicted value is less than the predictive suspend threshold value; andautomatically resuming operation of the infusion device comprises automatically enabling operation of the infusion device to deliver the fluid to the user in accordance with a delivery command configured to regulate the current amount to the steady state threshold value in response to determining the current amount of active fluid of the user is less than the steady state threshold value. 6. A method of operating an infusion device operable to deliver fluid to a body of a user, the fluid influencing a physiological condition in the body, the method comprising: automatically suspending operation of the infusion device to deliver the fluid to the user based at least in part on a current measurement value for the physiological condition of the user;determining a current amount of active fluid in the body of the user;determining a minimum threshold amount of active fluid for the user;after automatically suspending operation of the infusion device, when the current amount of active fluid is less than the minimum threshold amount, automatically resuming operation of the infusion device to deliver the fluid to the user to regulate the current amount of active fluid to the minimum threshold amount of active fluid based on a difference between the current amount of active fluid to the minimum threshold amount of active fluid when the current measurement value for the physiological condition of the user is less than a threshold value for the physiological condition of the user; andautomatically suspending the delivery of the fluid upon transitioning from a closed-loop mode regulating the physiological condition of the user to a target value to an open-loop mode when the current amount is greater than the minimum threshold amount. 7. The method of claim 6, further comprising, after automatically suspending the delivery, automatically enabling operation of the infusion device in accordance with the open-loop mode to deliver the fluid to the user when the current amount is less than the minimum threshold amount. 8. A computer-readable medium having computer-executable instructions stored thereon that, when executed by a processing system associated with the infusion device, cause the processing system to perform the method of claim 1. 9. A method of operating an infusion device operable to deliver insulin to a body of a user, the method comprising: automatically suspending operation of a motor of the infusion device based at least in part on a current glucose measurement value for the user;identifying a minimum insulin on board for the user;identifying a current insulin on board for the user;generating an insulin on board delivery command configured to regulate the current insulin on board to the minimum insulin on board based on a difference between the current insulin on board and the minimum insulin on board;prior to operating the infusion device in accordance with the insulin on board delivery command, determining the current glucose measurement value for the user is greater than a resume enable threshold value prior to automatically enabling operation of the motor in response to determining the current insulin on board is less than the minimum insulin on board; andoperating the infusion device in accordance with the insulin on board delivery command when a closed-loop delivery command generated based on a difference between the current glucose measurement value for the user and a target glucose value for the user is less than or equal to zero. 10. The method of claim 9, further comprising: generating the closed-loop delivery command based on the difference between the current glucose measurement value for the user and the target glucose value for the user, the closed-loop delivery command being configured to regulate the current glucose measurement value to the target glucose value; andoperating the infusion device in accordance with the closed-loop delivery command when the closed-loop delivery command is greater than zero. 11. The method of claim 9, further comprising identifying a nominal basal rate of delivery of the insulin, wherein identifying the minimum insulin on board comprises: determining a reduced delivery rate based on the nominal basal rate; andidentifying the minimum insulin on board as a steady state insulin on board resulting from the reduced delivery rate. 12. A method of operating an infusion device operable to deliver fluid to a body of a user, the fluid influencing a physiological condition in the body, the infusion device comprising a motor operable to deliver the fluid to the body of the user and a control module coupled to the motor, the method comprising: operating, by the control module, the motor to deliver the fluid based on a difference between a current measurement value for the physiological condition and a target value for the physiological condition when the current measurement value is greater than the target value;automatically suspending operation of the infusion device to deliver the fluid to the user based at least in part on the current measurement value;determining a current amount of active fluid in the body of the user;determining a minimum threshold amount of active fluid for the user; andafter automatically suspending operation of the infusion device, when the current amount of active fluid is less than the minimum threshold amount, automatically resuming operation of the infusion device to deliver the fluid to the user to regulate the current amount of active fluid to the minimum threshold amount of active fluid based on a difference between the current amount of active fluid to the minimum threshold amount of active fluid when the current measurement value for the physiological condition of the user is less than a threshold value for the physiological condition of the user, wherein automatically resuming operation of the infusion device to modify delivery of the fluid to the user based on a relationship between the current amount and the minimum threshold comprises: operating, by the control module, the motor to deliver the fluid to regulate the current amount of the active fluid in the body of the user to the minimum threshold amount for the active fluid in the body of the user when the current amount is less than the minimum threshold amount and the current measurement value is less than or equal to the target value; andsuspending operation of the motor when the current amount is greater than an upper threshold amount and the current measurement value is less than or equal to the target value. 13. The method of claim 12, the fluid comprising insulin, wherein: the current measurement value comprises a current glucose measurement value for the user;the minimum threshold comprises a minimum insulin on board; andthe upper threshold comprises a steady-state insulin on board resulting from a basal infusion rate. 14. The method of claim 12, further comprising: suspending, by the control module, operation of the motor based on the current measurement value; andautomatically enabling, by the control module, operation of the motor when the current amount of the active fluid in the body of the user is less than the threshold amount. 15. The method of claim 9, wherein generating the delivery command comprises determining the delivery command using equation uIOB(t)=KPmin(eIOB(t)+1τ1min∫0teIOB(τ)ⅆτ), where uIOB(t) represents the delivery command, eIOB(t) represents the difference between the current insulin on board and the minimum insulin on board, KPmin is a proportional gain coefficient for regulating the current insulin on board to the minimum insulin on board, and τ1min is the integral time constant for regulating the current insulin on board to the minimum insulin on board. 16. The method of claim 9, wherein identifying the minimum insulin on board comprises calculating the minimum insulin on board by applying a final value theorem using at least one of a minimum insulin infusion rate input, a nominal basal delivery rate, a preprogrammed basal delivery rate, and a historical average delivery rate for the user.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (197)
Batina, William P.; White, Robert M., Acquisition circuit for cardiac pacer.
Schulman Joseph H. ; Lucisano Joseph Y. ; Shah Rajiv ; Byers Charles L. ; Pendo Shaun M., Alumina insulation for coating implantable components and other microminiature devices.
Tune Joel (Antioch IL) Anderson Robert L. (Boulder CO) Blankenship Larry (Boulder CO) Colesworthy ; III Daniel C. (Boulder CO) Heim Warren P. (Boulder CO) Miller ; III Scott A. (Boulder CO) Sherman B, Ambulatory infusion pump.
Coutr James E. (Concord MA) Griffin Wayne P. (Dracut MA) Crisler Charles M. (Windham NH), An infusion management and pumping system having an alarm handling system.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S. ; Friedman Keith A. ; Colman Fredric C., Analyte monitoring device and methods of use.
Steil, Garry M.; Rebrin, Kerstin; Goode, Jr., Paul V.; Mastrototaro, John J.; Purvis, Richard E.; Van Antwerp, William P.; Shin, John J.; Talbot, Cary D., Closed loop system for controlling insulin infusion.
Prestele Karl (Erlangen DEX) Franetzki Manfred (Uttenreuth DEX) Reif Erich (Erlangen DEX), Device for the infusion of fluids into the human or animal body.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Electrochemical analyte.
James Say ; Michael F. Tomasco ; Adam Heller ; Yoram Gal IL; Behrad Aria ; Ephraim Heller ; Phillip John Plante ; Mark S. Vreeke, Electrochemical analyte sensor.
Gibson, Scott R.; Shah, Rajiv; Chernoff, Edward; Byers, Charles, Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat Zu Lubeck ; Klinik Fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat zu Lubeck ; Klinik fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Flex circuit connector.
Dempsey Michael K. (Acton MA) Kotfila Mark S. (Chelmsford MA) Snyder Robert J. (Westford MA), Flexible patient monitoring system featuring a multiport transmitter.
Yap, Darren Y. K.; Gulati, Poonam; Kovelman, Paul H.; Van Antwerp, William P.; Enegren, Bradley J.; Geismar, Eric P.; Hudak, Philip J.; McConnell, Susan; Moberg, Sheldon B., Fluid reservoir piston.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville R. (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Bever, Glucose monitoring system.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville Rey (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Beve, Glucose sensor assembly.
McIvor, K. Collin; Cabernoch, James L.; Branch, Kevin D.; Van Antwerp, Nannette M.; Halili, Edgardo C.; Mastrototaro, John J., Glucose sensor package system.
Allen Douglas J. (Indianapolis IN) Johnson Kirk W. (Indianapolis IN) Nevin Robert S. (Indianapolis IN), Hydrophilic polyurethane membranes for electrochemical glucose sensors.
Schulman Joseph H. ; Byers Charles L. ; Adomian Gerald E. ; Colvin Michael S., Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces.
Wilson George S. (Lawrence KS) Bindra Dilbir S. (Lawrence KS) Hill Brian S. (Lawrence KS) Thevenot Daniel R. (Paris Cedex FRX) Sternberg Robert (Thiais FRX) Reach Gerard (Paris Cedex KS FRX) Zhang Ya, Implantable glucose sensor.
Meadows, Paul M.; Mann, Carla M.; Tsukamoto, Hisashi; Chen, Joey, Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries.
Gargano Diane A. ; Flachbart Eric J. ; Cowen Barry ; Duh Monica ; Rudser ; Jr. John L. ; Zhen Ken ; Noble Lynn ; Warhurst Julian ; Pedraza Luis, Infusion pump for at least one syringe.
Coutre James E. (114 Stone Root La. Concord MA 01742) Griffin Wayne P. (55 Surrey La. Dracut MA 01826) Crisler Charles M. (10 Sunridge Rd. Windham NH 03087), Infusion pump management system for suggesting an adapted course of therapy.
Causey ; III James D. (Simi Valley CA) Schloss Harold C. (Los Angeles CA) Snell Jeffery D. (Northridge CA), Interactive programming and diagnostic system for use with implantable pacemaker.
Say, James L.; Sakslund, Henning; Tomasco, Michael F.; Audett, Jay D.; Cho, Hyun; Yamasaki, Duane O.; Heller, Adam, Mass transport limited in vivo analyte sensor.
Castellano Thomas P. (Beverly Hills CA) Schumacher Robert (Beverly Hills CA), Medication delivery device with a microprocessor and characteristic monitor.
Colman Fredric C. (Granada Hills CA) Purvis Richard E. (Glendale CA), Medication infusion system having optical motion sensor to detect drive mechanism malfunction.
Peterson Bruce A. (Milwaukie OR) Hogard Michael E. (Oregon City OR) Johnson Harley D. (Portland OR) Kelly Thomas D. (Portland OR) Long Jean M. (Portland OR) Preston ; Jr. William G. (Portland OR), Method and apparatus for kidney dialysis.
Joseph H. Schulman ; Joseph Y. Lucisano ; Rajiv Shah ; Charles L. Byers ; Shaun M. Pendo, Method of applying insulation for coating implantable components and other microminiature devices.
Feldman, Benjamin J.; Heller, Adam; Heller, Ephraim; Mao, Fei; Vivolo, Joseph A.; Funderburk, Jeffery V.; Colman, Fredric C.; Krishnan, Rajesh, Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator.
Moberg, Sheldon B.; Causey, III, James D.; Bare, Rex O.; Scherer, Andrew J.; Sargent, Bradley J., Methods, apparatuses, and uses for infusion pump fluid pressure and force detection.
Sheldon B. Moberg ; James D. Causey, III ; Rex O. Bare ; Andrew J. Scherer ; Bradley J. Sargent, Methods, apparatuses, and uses for infusion pump fluid pressure and force detection.
Brown Stephen J. ; Jensen Erik K., On-line health education and feedback system using motivational driver profile coding and automated content fulfillment.
Roizen Michael (Chicago IL) Turcotte ; II William E. (Oak Park IL) Pfisterer Richard E. (Arlington Heights IL), Portable medical interactive test selector having plug-in replaceable memory.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Process for producing an electrochemical biosensor.
Livingston John H. (Los Angeles CA) Frye Ward K. (San Luis Obispo CA) Field Jeffrey F. (Northridge CA), Proctective case for a medication infusion pump.
Sancoff Gregory E. (Leucadia CA) McWilliams Mark (San Diego CA) Barr Howard S. (Escondido CA) Cordner ; Jr. Edward T. (Carlsbad CA) Barton Russell C. (Monrovia CA), Programmable infusion system.
Shin, John J.; Holtzclaw, Kris R.; Dangui, Nandita D.; Kanderian, Jr., Sami; Mastrototaro, John J.; Hong, Peter I., Real time self-adjusting calibration algorithm.
Langen Pauline A. (Simsbury CT) Katz Jeffrey S. (West Hartford CT) Dempsey Gayle (Needham MA) Pompano James (East Haven CT), Remote monitoring of high-risk patients using artificial intelligence.
Epstein Paul (Brookline MA) Petschek Harry (Lexington MA) LaWhite Eric (South Royalton VT) Strohl Clair (Norfolk MA) Coyne Henry (Framington MA) Kaleskas Edward (Jefferson MA) Adaniya George (Swampsc, Remotely programmable infusion system.
Lundquist Ingemar H. (Pebble Beach CA) Tarczy-Hornoch Zoltan (Berkeley CA) Kardos Thomas J. (Laguna Beach CA), Retroperfusion and retroinfusion control apparatus, system and method.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Nason Clyde K. (25745 N. Player Dr. Valencia CA 91355) Culp Gordon W. (13832 Haynes St. Van Nuys CA 91401), Solenoid drive apparatus for an external infusion pump.
Starkweather, Timothy J.; Lebel, Ronald J.; Shah, Rajiv; Miller, Michael E., System and method for providing closed loop infusion formulation delivery.
Aoki Thomas T. (1021 El Sur Way Sacramento CA 95825), System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof.
Tacklind Christopher A. (Palo Alto CA) Sanders Matthew H. (Los Altos Hills CA) Walne Geoffrey B. (Atherton CA), System for monitoring and reporting medical measurements.
Blomquist Michael L. (Coon Rapids MN) Peterson Thomas L. (Shoreview MN), Systems and methods for operating ambulatory medical devices such as drug delivery devices.
Mann, Alfred E.; Purvis, Richard E.; Mastrototaro, John J.; Causey, James D.; Henke, James; Hong, Peter; Livingston, John H.; Hague, Clifford W.; Hite, Brad T., Telemetered characteristic monitor system and method of using the same.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Transcutaneous sensor insertion set.
Gerety, Eugene P.; Strempski, Richard A.; Sardi, Stephen G., Two-dimensional printed code for storing biometric information and integrated off-line apparatus for reading same.
Carter,Scott J.; Flanders,Edward L.; Hannah,Stephen E., Wireless LAN architecture for integrated time-critical and non-time-critical services within medical facilities.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.